Juha Lievonen

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.

TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.

Journal: iScience
Published: February 23, 2026

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Journal: Acta haematologica
Published: December 15, 2025

Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.

Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.

Journal: Annals of hematology
Published: September 13, 2024

Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.

Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.

Journal: Annals of hematology
Published: February 27, 2024

Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study.

Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study.

Journal: Annals of hematology
Published: September 06, 2023

Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland.

Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland.

Journal: EJHaem
Published: July 03, 2023

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families.

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families.

Journal: EJHaem
Published: July 22, 2022

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016.

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016.

Journal: Annals of hematology
Published: April 07, 2022

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.

Journal: Frontiers in cell and developmental biology
Published: June 09, 2021

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.

Journal: Cancers
Published: January 08, 2021

Characteristics and survival trends in Finnish multiple myeloma patients-a nationwide real-world evidence study.

Characteristics and survival trends in Finnish multiple myeloma patients-a nationwide real-world evidence study.

Journal: Annals of hematology
Published: December 23, 2020

Prognostic significance of esterase gene expression in multiple myeloma.

Prognostic significance of esterase gene expression in multiple myeloma.

Journal: British journal of cancer
Published: July 14, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026